Crescent Capital BDC (CCAP) Stock Forecast, Price Target & Predictions
CCAP Stock Forecast
Crescent Capital BDC stock forecast is as follows: an average price target of $18.50 (represents a -3.29% downside from CCAP’s last price of $19.13) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.
CCAP Price Target
The average price target for Crescent Capital BDC (CCAP) is $18.50 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $19.00 to $18.00. This represents a potential -3.29% downside from CCAP's last price of $19.13.
CCAP Analyst Ratings
According to 3 Wall Street analysts, Crescent Capital BDC's rating consensus is 'Buy'. The analyst rating breakdown for CCAP stock is 0 'Strong Buy' (0.00%), 2 'Buy' (66.67%), 1 'Hold' (33.33%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Crescent Capital BDC Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| May 13, 2024 | Finian O'Shea | Wells Fargo | $18.00 | $18.19 | -1.04% | -5.91% |
| May 10, 2024 | Robert Dodd | Raymond James | $19.00 | $18.18 | 4.48% | -0.68% |
| Apr 25, 2022 | - | Wells Fargo | $18.50 | $17.80 | 3.91% | -3.29% |
The latest Crescent Capital BDC stock forecast, released on May 13, 2024 by Finian O'Shea from Wells Fargo, set a price target of $18.00, which represents a -1.04% decrease from the stock price at the time of the forecast ($18.19), and a -5.91% decrease from CCAP last price ($19.13).
Crescent Capital BDC Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 2 |
| Avg Price Target | - | - | $18.50 |
| Last Closing Price | $19.13 | $19.13 | $19.13 |
| Upside/Downside | -100.00% | -100.00% | -3.29% |
In the current month, the average price target of Crescent Capital BDC stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Crescent Capital BDC's last price of $19.13. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| May 13, 2024 | Wells Fargo | Equal-Weight | Equal-Weight | Hold |
| May 10, 2024 | Raymond James | Outperform | Outperform | Hold |
| Nov 13, 2023 | Wells Fargo | - | Equal-Weight | Downgrade |
| Aug 12, 2022 | Oppenheimer | - | Outperform | Upgrade |
Crescent Capital BDC's last stock rating was published by Wells Fargo on May 13, 2024. The company gave CCAP a "Equal-Weight" rating, the same as its previous rate.
Crescent Capital BDC Financial Forecast
Crescent Capital BDC Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $48.15M | - | $9.96M | $4.78M | $28.99M | $679.00K | $18.21M | $16.97M | $17.17M | $31.23M | $19.56M | $32.45M | $36.42M | $54.32M | $18.83M | $7.52M |
| Avg Forecast | $41.96M | $42.41M | $42.87M | $43.78M | $43.32M | $43.73M | $44.64M | $45.60M | $47.16M | $48.89M | $47.65M | $47.70M | $47.73M | $46.99M | $45.63M | $36.20M | $32.14M | $29.02M | $25.97M | $25.94M | $24.98M | $22.96M | $21.25M | $20.53M | $19.63M | $19.92M | $18.08M | $15.59M | $15.01M |
| High Forecast | $42.71M | $43.17M | $43.64M | $44.57M | $44.09M | $44.51M | $45.44M | $47.06M | $47.37M | $49.67M | $47.65M | $47.70M | $47.92M | $48.10M | $46.45M | $36.85M | $32.72M | $29.02M | $25.97M | $25.94M | $24.98M | $22.96M | $21.25M | $20.53M | $19.63M | $19.92M | $18.08M | $15.59M | $15.01M |
| Low Forecast | $41.20M | $41.65M | $42.10M | $43.00M | $42.54M | $42.94M | $43.84M | $44.12M | $46.95M | $48.00M | $47.65M | $47.70M | $47.53M | $45.96M | $44.81M | $35.55M | $31.56M | $29.02M | $25.97M | $25.94M | $24.98M | $22.96M | $21.25M | $20.53M | $19.63M | $19.92M | $18.08M | $15.59M | $15.01M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 4 | 2 | 1 | 2 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.02% | - | 0.28% | 0.15% | 1.00% | 0.03% | 0.70% | 0.68% | 0.75% | 1.47% | 0.95% | 1.65% | 1.83% | 3.00% | 1.21% | 0.50% |
Crescent Capital BDC's average Quarter revenue forecast for Dec 23 based on 2 analysts is $47.73M, with a low forecast of $47.53M, and a high forecast of $47.92M. CCAP's average Quarter revenue forecast represents a -0.88% decrease compared to the company's last Quarter revenue of $48.15M (Sep 23).
Crescent Capital BDC EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 4 | 2 | 1 | 2 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $22.07M | - | $19.10M | $13.09M | $5.87M | $25.87M | $21.20M | $13.39M | $22.93M | $38.44M | $26.01M | $1.69M | $42.15M | $60.35M | $-70.41M | $12.88M |
| Avg Forecast | $7.69M | $7.77M | $7.86M | $8.02M | $7.94M | $8.01M | $8.18M | $8.36M | $8.64M | $8.96M | $8.73M | $33.09M | $8.75M | $8.61M | $8.36M | $26.16M | $14.38M | $28.49M | $25.50M | $20.68M | $24.53M | $22.55M | $20.87M | $20.16M | $19.27M | $19.56M | $17.75M | $-63.37M | $14.74M |
| High Forecast | $7.83M | $7.91M | $8.00M | $8.17M | $8.08M | $8.16M | $8.33M | $8.62M | $8.68M | $9.10M | $8.73M | $39.71M | $8.78M | $8.82M | $8.51M | $31.39M | $17.25M | $28.49M | $25.50M | $24.81M | $24.53M | $22.55M | $20.87M | $20.16M | $19.27M | $19.56M | $17.75M | $-50.70M | $14.74M |
| Low Forecast | $7.55M | $7.63M | $7.72M | $7.88M | $7.80M | $7.87M | $8.04M | $8.09M | $8.61M | $8.80M | $8.73M | $26.47M | $8.71M | $8.42M | $8.21M | $20.93M | $11.50M | $28.49M | $25.50M | $16.54M | $24.53M | $22.55M | $20.87M | $20.16M | $19.27M | $19.56M | $17.75M | $-76.05M | $14.74M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.56% | - | 0.73% | 0.91% | 0.21% | 1.01% | 1.03% | 0.55% | 1.02% | 1.84% | 1.29% | 0.09% | 2.15% | 3.40% | 1.11% | 0.87% |
2 analysts predict CCAP's average Quarter EBITDA for Dec 23 to be $8.75M, with a high of $8.78M and a low of $8.71M. This is -60.37% lower than Crescent Capital BDC's previous annual EBITDA (Sep 23) of $22.07M.
Crescent Capital BDC Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 4 | 2 | 1 | 2 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $22.62M | - | $7.78M | $2.60M | $-2.38M | $-890.00K | $16.21M | $12.84M | $16.68M | $32.58M | $21.54M | $34.46M | $38.34M | $56.42M | $-74.55M | $9.18M |
| Avg Forecast | $17.05M | $17.23M | $17.42M | $17.97M | $18.22M | $18.48M | $19.10M | $19.57M | $20.64M | $21.43M | $21.52M | $25.31M | $21.13M | $20.67M | $20.28M | $20.00M | $13.78M | $16.06M | $15.33M | $15.81M | $15.32M | $15.38M | $16.68M | $21.99M | $17.05M | $17.79M | $15.94M | $-67.09M | $17.79M |
| High Forecast | $17.44M | $17.63M | $17.82M | $18.39M | $18.64M | $18.91M | $19.55M | $20.32M | $21.01M | $21.80M | $21.53M | $30.37M | $21.50M | $21.41M | $20.75M | $24.01M | $16.54M | $16.06M | $15.33M | $18.98M | $15.32M | $15.38M | $16.68M | $26.39M | $17.05M | $17.79M | $15.94M | $-53.67M | $17.79M |
| Low Forecast | $16.65M | $16.83M | $17.01M | $17.55M | $17.79M | $18.05M | $18.65M | $18.44M | $20.26M | $20.92M | $21.52M | $20.24M | $20.76M | $19.93M | $19.80M | $16.00M | $11.03M | $16.06M | $15.33M | $12.65M | $15.32M | $15.38M | $16.68M | $17.60M | $17.05M | $17.79M | $15.94M | $-80.51M | $17.79M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.09% | - | 0.39% | 0.19% | -0.15% | -0.06% | 1.03% | 0.84% | 1.08% | 1.95% | 0.98% | 2.02% | 2.16% | 3.54% | 1.11% | 0.52% |
Crescent Capital BDC's average Quarter net income forecast for Dec 23 is $21.13M, with a range of $20.76M to $21.50M. CCAP's average Quarter net income forecast represents a -6.59% decrease compared to the company's last Quarter net income of $22.62M (Sep 23).
Crescent Capital BDC SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 4 | 2 | 1 | 2 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.00M | - | $1.21M | $1.10M | $1.08M | $1.05M | $1.26M | $919.00K | $1.34M | $1.30M | $1.31M | $-2.36M | $-2.21M | $-2.40M | $-1.89M | $-1.50M |
| Avg Forecast | $4.55M | $4.60M | $4.65M | $4.75M | $4.70M | $4.75M | $4.85M | $4.95M | $5.12M | $5.31M | $5.17M | $1.97M | $5.18M | $5.10M | $4.95M | $1.56M | $986.83K | $3.29M | $2.95M | $1.23M | $2.84M | $2.61M | $2.41M | $1.34M | $2.23M | $2.26M | $2.05M | $-1.70M | $1.70M |
| High Forecast | $4.64M | $4.69M | $4.74M | $4.84M | $4.79M | $4.83M | $4.93M | $5.11M | $5.14M | $5.39M | $5.17M | $2.37M | $5.20M | $5.22M | $5.04M | $1.87M | $1.18M | $3.29M | $2.95M | $1.48M | $2.84M | $2.61M | $2.41M | $1.60M | $2.23M | $2.26M | $2.05M | $-1.36M | $1.70M |
| Low Forecast | $4.47M | $4.52M | $4.57M | $4.67M | $4.62M | $4.66M | $4.76M | $4.79M | $5.10M | $5.21M | $5.17M | $1.58M | $5.16M | $4.99M | $4.86M | $1.25M | $789.46K | $3.29M | $2.95M | $987.32K | $2.84M | $2.61M | $2.41M | $1.07M | $2.23M | $2.26M | $2.05M | $-2.04M | $1.70M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.20% | - | 0.77% | 1.11% | 0.33% | 0.35% | 1.03% | 0.32% | 0.51% | 0.54% | 0.98% | -1.06% | -0.98% | -1.17% | 1.11% | -0.88% |
Crescent Capital BDC's average Quarter SG&A projection for Dec 23 is $5.18M, based on 2 Wall Street analysts, with a range of $5.16M to $5.20M. The forecast indicates a 417.55% rise compared to CCAP last annual SG&A of $1.00M (Sep 23).
Crescent Capital BDC EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 4 | 2 | 1 | 2 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $0.59 | - | $0.24 | $1.69 | $-0.08 | $-0.03 | $0.52 | $0.46 | $0.59 | $1.16 | $0.76 | $1.22 | $1.36 | $2.00 | $-2.84 | $0.35 |
| Avg Forecast | $0.46 | $0.47 | $0.47 | $0.48 | $0.49 | $0.50 | $0.52 | $0.53 | $0.56 | $0.58 | $0.58 | $0.58 | $0.57 | $0.56 | $0.55 | $0.46 | $0.44 | $0.43 | $0.41 | $0.41 | $0.41 | $0.41 | $0.45 | $0.47 | $0.46 | $0.48 | $0.43 | $0.40 | $0.48 |
| High Forecast | $0.47 | $0.48 | $0.48 | $0.50 | $0.50 | $0.51 | $0.53 | $0.55 | $0.57 | $0.59 | $0.58 | $0.58 | $0.58 | $0.58 | $0.56 | $0.47 | $0.45 | $0.43 | $0.41 | $0.41 | $0.41 | $0.41 | $0.45 | $0.47 | $0.46 | $0.48 | $0.43 | $0.40 | $0.48 |
| Low Forecast | $0.45 | $0.45 | $0.46 | $0.47 | $0.48 | $0.49 | $0.50 | $0.50 | $0.55 | $0.56 | $0.58 | $0.58 | $0.56 | $0.54 | $0.53 | $0.45 | $0.43 | $0.43 | $0.41 | $0.41 | $0.41 | $0.41 | $0.45 | $0.47 | $0.46 | $0.48 | $0.43 | $0.40 | $0.48 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.06% | - | 0.52% | 3.87% | -0.18% | -0.07% | 1.27% | 1.11% | 1.42% | 2.58% | 1.62% | 2.66% | 2.83% | 4.65% | -7.10% | 0.73% |
According to 2 Wall Street analysts, Crescent Capital BDC's projected average Quarter EPS for Dec 23 is $0.57, with a low estimate of $0.56 and a high estimate of $0.58. This represents a -3.37% decrease compared to CCAP previous annual EPS of $0.59 (Sep 23).
Crescent Capital BDC Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| PTMN | Portman Ridge Finance | $17.75 | $26.00 | 46.48% | Strong Buy |
| TPVG | TriplePoint Venture Growth BDC | $8.53 | $11.15 | 30.72% | Hold |
| GBDC | Golub Capital BDC | $15.40 | $17.50 | 13.64% | Buy |
| WHF | WhiteHorse Finance | $11.85 | $12.00 | 1.27% | Buy |
| CCAP | Crescent Capital BDC | $18.71 | $18.50 | -1.12% | Buy |
| CGBD | Carlyle Secured Lending | $17.52 | $16.00 | -8.68% | Hold |
| TCPC | BlackRock TCP Capital | $10.58 | $8.00 | -24.39% | Hold |